Plain-English translation of NCT07457437 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When people take tirzepatide (a newer weight loss medication), they can lose a lot of weight—but sadly, some of that weight loss comes from muscle, not just fat. This study is testing whether doing supervised resistance exercise (strength training with bands and weights) alongside the medication can help preserve or even build back muscle mass in women aged 25–50 who are overweight or obese.
The concern is that while this medication works well for weight loss, losing too much muscle can leave people weaker and at higher risk of serious health problems later—especially if they regain weight after stopping the medication. Researchers want to know if exercise can solve this problem by keeping muscles strong during treatment.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups. Both groups take the weight loss medication for 20 weeks. However, if you're in the exercise group, you'll also attend supervised strength training sessions 4 times per week for the full 20 weeks—these sessions take place in person. Researchers will measure your muscle mass, strength, and physical function at the beginning and end of the study to see if exercise made a difference.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom